RT @JavierHasse: .@PharmaGw Analyst Expects $475M In Sales Of CBD Drug Expidiolex This Year $GWPH
By Javier Hasse / January 16, 2020 / benzinga.com / Article Link
GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) exceeded fourth-quarter estimates for Epidiolex sales, notching $108 million in revenue for the CBD drug, according to the company...Read full news